Stock Analysis on Net
Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

$22.49

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Paying user area

Try for free

Shockwave Medical Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Shockwave Medical Inc., consolidated cash flow statement (quarterly data)

US$ in thousands

Microsoft Excel
3 months ended: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (loss)
Depreciation and amortization
(Income) loss from equity method investment
Stock-based compensation
Non-cash lease expense
Amortization of premium and discount on available-for-sale securities
Loss on write down of fixed assets
Loss on extinguishment of debt
Deferred income taxes
Change in fair value of warrant liability
Amortization of debt issuance costs
Foreign currency remeasurement
Change in fair value of contingent consideration
Accounts receivable
Inventory
Prepaid expenses and other current assets
Other assets
Accounts payable
Accrued and other current liabilities
Lease liabilities
Long-term income tax liability
Changes in operating assets and liabilities
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities
Net cash provided by (used in) operating activities
Purchase of available-for-sale securities
Proceeds from maturities of available-for-sale securities
Purchase of property and equipment
Business combination, net of cash acquired
Net cash (used in) provided by investing activities
Proceeds from issuance of common stock upon initial public offering, net of issuance costs paid
Proceeds from issuance of common stock in private placement
Payment of deferred offering costs
Proceeds from issuance of common stock in public offering, net of issuance costs paid
Payments of taxes withheld on net settled vesting of restricted stock units
Proceeds from stock option exercises
Proceeds from issuance of common stock under employee stock purchase plan
Proceeds from convertible debt, net
Purchase of capped calls related to convertible debt
Principal payment of debt
Proceeds from debt financing
Payment of assumed warrant liability
Proceeds from warrant exercises
Net cash provided by (used in) financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase (decrease) in cash, cash equivalents and restricted cash

Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Cash flow statement item Description The company
Net cash provided by (used in) operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Shockwave Medical Inc. net cash provided by (used in) operating activities increased from Q3 2023 to Q4 2023 but then decreased significantly from Q4 2023 to Q1 2024.
Net cash (used in) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Shockwave Medical Inc. net cash (used in) provided by investing activities increased from Q3 2023 to Q4 2023 and from Q4 2023 to Q1 2024.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Shockwave Medical Inc. net cash provided by (used in) financing activities decreased from Q3 2023 to Q4 2023 but then slightly increased from Q4 2023 to Q1 2024.